Top compounds associated with response to SYT17


Feature Type Standardized
Nominal ANOVA
mRNA GSK-650394 GDSC1000 pan-cancer AAC -0.13 0.0008
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.13 0.0009
mRNA SN-38 GDSC1000 pan-cancer AAC -0.12 0.001
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.19 0.001
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.12 0.001
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.13 0.002
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.14 0.002
Download CSV